Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients
Kolodny, E.H.; Ullman, M.D.; Mankin, H.J.; Raghavan, S.S.; Topol, J.; Sullivan, J.L.
Progress in Clinical and Biological Research 95: 33-65
1982
ISSN/ISBN: 0361-7742 PMID: 6289358 Document Number: 184100
Document emailed within 1 workday
Related Documents
Svennerholm, L.; Dreborg, S.; Erikson, A.; Groth, C.G.; Hillborg, P.O.; Håkansson, G.; Nilsson, O.; Tibblin, E. 1982: Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations Progress in Clinical and Biological Research 95: 67-94Pérez-Calvo, J.; Giraldo, P.; Pastores, G.M.; Fernández-Galán, M.; Martín-Nuñez, G.; Pocoví, M. 2003: Extended interval between enzyme therapy infusions for adult patients with Gaucher's disease type 1 Journal of Postgraduate Medicine 49(2): 127-131
Liu, Q.; Zhao, J.; Wang, Z.-x.; Zhang, W.; Yuan, Y. 2013: Clinical features and acid alpha-glucosidase gene mutation in 7 Chinese patients with glycogen storage disease type Ii Zhonghua Yi Xue Za Zhi 93(25): 1981-1985
Pérez-Calvo, J.I.; Giraldo, P.; Giralt, M. 1997: Alglucerase treatment of type i Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease Sangre 42(3): 189-194
Kiryu, K.; Morita, H.; Fujita, Y.; Kawasumi, M.; Shinzato, T.; Tsuruta, Y.; Nakai, S.; Maeda, K. 1994: Phenotypic expressions of type I, III, IV, V, and Vi collagens in patients with diabetic nephropathy: immunohistochemical comparison between HD and non-HD patients Nihon Jinzo Gakkai Shi 36(4): 365-373
Ozmen, M.; Yilmaz, Y.; Calişkan, M.; Minareci, O.; Aydinli, N. 2000: Clinical features of 21 patients with lissencephaly type i (agyria-pachygyria) Turkish Journal of Pediatrics 42(3): 210-214
Friedman, D.J.; Lane, A.B.; Katz, S.; Jenkins, T. 1978: Glycogen storage disease type IV diagnosed biochemically. A case report South African Medical Journal 54(7): 289-291
Jin, H-Bin.; Gu, Z-Ying.; Yu, C-Hui.; Li, Y-Ming. 2005: Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(3): 389-392
Inoue, M.; Oishi, C.; Shimajiri, Y.; Furuta, M.; Ueyama, M.; Sanke, T. 2008: Clinical usefulness of measurement of urine type IV collagen for detection of early phase of nephropathy in type 2 diabetic patients Rinsho Byori. Japanese Journal of Clinical Pathology 56(7): 564-569
Wykretowicz, A. 2010: Comment to article Leptin in acute myocardial infarction and period of convalescence in patients with type 2 diabetes mellitus Kardiologia polska 68(6): 654
Devine, E.A.; Beighton, P.; Petersen, E.M.; Desnick, R.J. 1982: Genetic heterogeneity in type i Gaucher disease Progress in Clinical and Biological Research 95: 495-510
Kaminsky, P.; Klein, M.; Jacob, C.; Deibener, J.; Duc, M. 1995: Biclonal gammapathy in type i Gaucher disease Presse Medicale 24(30): 1400
Antonaci, S.; Jirillo, E.; Garofalo, A.R.; Polignano, A.; Resta, F.; Pugliese, P.; Capurso, A.; Bonomo, L. 1988: Cell-mediated immune response in patients with type IIa, type IIb and type IV primary hyperlipoproteinaemia Cytobios 54(218-219): 181-189
Cano Ruiz, A.; Martín Scapa, A.; Monescillo Francia, A.; Moreno Caparrós, A. 1998: Gaucher's disease type I: an infrequent cause of portal hypertension Anales de Medicina Interna 15(9): 483-484
Redzić, A.; Begić, F. 2003: Type i Gaucher's disease--a rare genetic metabolic disease Medicinski Arhiv 57(3): 173-176
Huang, H.; Li, H.; Zheng, F.-p.; Lu, W.-n.; Dong, X.-h.; Ruan, Y. 2010: Clinical features and risk factors of renal damage in elderly and non-elderly patients with type 2 diabetes mellitus Zhonghua Yi Xue Za Zhi 90(14): 967-971
Zakharova, E.I.; Mikhaĭlova, S.V.; Proshliakova, T.I.; Rudenskaia, G.E. 2012: Clinical and genetic special features of Niemann-Pick disease, type C Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 12: 60-65
Boda, A.; Erdós, M.; Tóth, J.; Nagy, J.; Maródi, László. 2003: Rapidly developing bone destruction in a patient with type 1 Gaucher disease Orvosi Hetilap 144(13): 625-627
Parco, S.; Bruno, G.; Durighello, M.; Giorgini, R.; Simeone, R.; Bembi, B. 1999: Hematologic response in type i Gaucher's disease after enzyme replacement therapy Haematologica 84(4): 376-377
Niederau, C.; vom Dahl, S.; Häussinger, D. 1998: First long-term results of imiglucerase therapy of type 1 Gaucher disease European Journal of Medical Research 3(1-2): 25-30